Author: Maghzi, Amir Hadi; Houtchens, Maria K.; Preziosa, Paolo; Ionete, Carolina; Beretich, Biljana D.; Stankiewicz, James M.; Tauhid, Shahamat; Cabot, Ann; Berriosmorales, Idanis; Schwartz, Tamara H. W.; Sloane, Jacob A.; Freedman, Mark S.; Filippi, Massimo; Weiner, Howard L.; Bakshi, Rohit
Title: COVID-19 in teriflunomide-treated patients with multiple sclerosis Cord-id: cdp49bk5 Document date: 2020_6_3
ID: cdp49bk5
Snippet: The outbreak of a severe acute respiratory syndrome caused by a novel coronavirus (COVID-19), has raised health concerns for patients with multiple sclerosis (MS) who are commonly on long-term immunotherapies. Managing MS during the pandemic remains challenging with little published experience and no evidence-based guidelines. We present five teriflunomide-treated patients with MS who subsequently developed active COVID-19 infection. The patients continued teriflunomide therapy and had self-limi
Document: The outbreak of a severe acute respiratory syndrome caused by a novel coronavirus (COVID-19), has raised health concerns for patients with multiple sclerosis (MS) who are commonly on long-term immunotherapies. Managing MS during the pandemic remains challenging with little published experience and no evidence-based guidelines. We present five teriflunomide-treated patients with MS who subsequently developed active COVID-19 infection. The patients continued teriflunomide therapy and had self-limiting infection, without relapse of their MS. These observations have implications for the management of MS in the setting of the COVID-19 pandemic.
Search related documents:
Co phrase search for related documents- activate immune cell and adaptive immune response: 1, 2
- activate immune cell and adaptive innate: 1, 2, 3
- activate immune cell and adaptive innate immunity: 1
- active infection and acute respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
- active infection and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
- active infection and adaptive immune response: 1, 2, 3, 4, 5
- active infection and adaptive innate: 1, 2, 3, 4, 5
- active infection and adaptive innate immunity: 1
- active infection and additional study: 1
- active infection and low grade fever: 1
Co phrase search for related documents, hyperlinks ordered by date